Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Clin Hemorheol Microcirc ; 58(4): 489-95, 2014.
Article in English | MEDLINE | ID: mdl-23603321

ABSTRACT

Systemic lupus erythematosus (SLE) is an autoimmune, chronic inflammatory, non-organ specific disease with an important morbimortality affecting several organs and systems. Oxidative stress is a well documented mechanism of red blood cells (RBC) mechanical impairment. Free radicals could produced, through lipid peroxidation, physical and chemical alterations in the cellular membrane properties modifying its composition, packing and lipid distribution on the membrane erythrocyte. The aim of the present work is to study the lipid peroxidation in the RBC membrane in SLE patients (n = 42) affecting so far the lipid membrane fluidity and erythrocyte deformability in comparison with healthy controls (n = 52). Malonildialdehyde (MDA) is a subrogate assessing lipidic peroxidation, rigidity index estimating erythrocyte deformability and the anisotropy coefficient estimating lipid membrane fluidity were used. Our results show that MDA values are increased, while erythrocyte deformability and membrane fluidity are significantly decreased in erythrocyte membrane from SLE patients in comparison with normal controls. The association of thiobarbituric acid reactive substances (TBARS) with membrane lipid fluidity and erythrocyte deformability confirms that the damage of membrane properties is produced by lipid peroxidation.


Subject(s)
Erythrocyte Membrane/metabolism , Lipid Peroxidation/physiology , Lupus Erythematosus, Systemic/blood , Adult , Erythrocytes/metabolism , Female , Humans , Membrane Fluidity/physiology , Middle Aged , Oxidative Stress/physiology
2.
Clin Hemorheol Microcirc ; 47(4): 279-85, 2011.
Article in English | MEDLINE | ID: mdl-21654057

ABSTRACT

Systemic Lupus Erythematosus (SLE) is an autoimmune, chronic inflammatory, non-organ specific disease. SLE patients present a high prevalence of thrombotic and arteriosclerotic disease. The aim of the present work was to study the erythrocyte aggregation kinetics, and the effect of plasma factors, namely, immunoglobulin and fibrinogen concentration, as well as cell factors such as deformability and erythrocyte membrane lipid fluidity on the erythrocyte aggregation, in SLE patients and healthy controls. The results show that SLE patients red blood cells aggregate at higher rate and the aggregates size are also greater than controls due to an increase of immunoglobulin and plasma fibrinogen. The negative correlation between aggregation parameters and rigidity index could point out that the altered deformability diminishes the erythrocyte aggregation. Correlation between rigidity index and anisotropy suggests that the decrease of membrane lipid fluidity might be a cause of deformability decrease. The erythrocyte aggregation increase in these patients could induce a decreased flow that might contribute to the thromboembolic process present in SLE patients.


Subject(s)
Erythrocyte Aggregation/physiology , Erythrocytes/pathology , Lupus Erythematosus, Systemic/blood , Adult , Cross-Sectional Studies , Erythrocyte Deformability , Erythrocyte Membrane/metabolism , Erythrocyte Membrane/pathology , Erythrocytes/metabolism , Female , Fibrinogen/metabolism , Humans , Immunoglobulins/metabolism , Lupus Erythematosus, Systemic/immunology , Male , Membrane Fluidity , Middle Aged
3.
Clin Hemorheol Microcirc ; 36(2): 105-10, 2007.
Article in English | MEDLINE | ID: mdl-17325434

ABSTRACT

Systemic scleroderma is an autoimmune disease, due to a connective tissue alteration characterized by extracellular matrix increase in the skin and internal organs. It is already known that the Raynaud's phenomenon and the microcapillary obliteration lead to ischemia and peripheral tissue injury. The ischemia-reperfusion phenomenon releases free radicals, that react with red blood cells (RBCs) membrane components originating lipid peroxidation and impairment of the ATP-Ca(++) pump, two possible mechanisms responsible of disease pathogenesis. Nifedipine is a Ca(++)-channel antagonist that has been used for a long time in Raynaud's phenomenon treatment. In the present study we were able to demonstrate that erythrocyte deformability and two other related variables such as membrane fluidity and osmotic fragility improve significantly with nifedipine therapy. It is likely that nifedipine inhibiting cytoplasmic calcium accumulation could restore some red blood cell membrane properties.


Subject(s)
Blood Viscosity/drug effects , Calcium Channel Blockers/pharmacology , Erythrocyte Deformability/drug effects , Nifedipine/pharmacology , Osmotic Fragility/drug effects , Scleroderma, Systemic/drug therapy , Adult , Female , Hemorheology/drug effects , Humans
SELECTION OF CITATIONS
SEARCH DETAIL
...